Cottrell T, Lotze M, Ali A, Bifulco C, Capitini C, Chow L
J Immunother Cancer. 2025; 13(3).
PMID: 40054999
PMC: 11891540.
DOI: 10.1136/jitc-2024-010928.
Kamel G, Attia R, Al-Noman H, Salama L
Mol Biol Rep. 2025; 52(1):290.
PMID: 40053260
DOI: 10.1007/s11033-025-10370-0.
Cesano A, Augustin R, Barrea L, Bedognetti D, Bruno T, Carturan A
J Immunother Cancer. 2025; 13(1).
PMID: 39824527
PMC: 11749597.
DOI: 10.1136/jitc-2024-008876.
Xie D, Lu G, Mai G, Guo Q, Xu G
MedComm (2020). 2025; 6(1):e70053.
PMID: 39802636
PMC: 11725047.
DOI: 10.1002/mco2.70053.
Guo Z, Zhu Z, Lin X, Wang S, Wen Y, Wang L
Biomark Res. 2024; 12(1):166.
PMID: 39741315
PMC: 11689763.
DOI: 10.1186/s40364-024-00714-6.
Construction of a disulfidptosis-related lncRNAs signature of the subtype, prognostic, and immunotherapy in neuroblastoma.
Fu Y, Zhang N, Wang J, Wang Y, Zhang D
Transl Cancer Res. 2024; 13(11):5909-5928.
PMID: 39697700
PMC: 11651765.
DOI: 10.21037/tcr-24-510.
Functional and phenotypic changes in natural killer cells expressing immune checkpoint receptors PD-1, CTLA-4, LAG-3, and TIGIT in non-small cell lung cancer: the comparative analysis of tumor microenvironment, peripheral venous blood, and....
Esen F, Cikman D, Engin A, Turna A, Batur S, Oz B
Immunol Res. 2024; 73(1):18.
PMID: 39695033
DOI: 10.1007/s12026-024-09573-7.
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers.
Berry L, Pullikuth A, Stearns K, Wang Y, Wagner C, Chou J
J Transl Med. 2024; 22(1):1048.
PMID: 39568014
PMC: 11577735.
DOI: 10.1186/s12967-024-05846-9.
CKAP2 Regulated by TFDP1 Promotes Metastasis and Proliferation of Colorectal Cancer through Affecting the Tumor Microenvironment.
Zhong Z, Cheng S, Liu Y
J Microbiol Biotechnol. 2024; 34(11):2211-2222.
PMID: 39403723
PMC: 11637825.
DOI: 10.4014/jmb.2407.07008.
The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer.
Gardani C, Diz F, Donde L, Rockenbach L, Laufer S, Morrone F
Front Immunol. 2024; 15:1455469.
PMID: 39355246
PMC: 11442216.
DOI: 10.3389/fimmu.2024.1455469.
Prognostic Value of Insulin Growth Factor-Like Receptor 1 (IGFLR1) in Stage II and III Colorectal Cancer and Its Association with Immune Cell Infiltration.
Jin R, Du F, Han X, Guo J, Song W, Xia Y
Appl Biochem Biotechnol. 2024; 197(1):427-442.
PMID: 39141178
PMC: 11748461.
DOI: 10.1007/s12010-024-05006-1.
The cytokine Meteorin-like inhibits anti-tumor CD8 T cell responses by disrupting mitochondrial function.
Jackson C, Pant A, Dinalankara W, Choi J, Jain A, Nitta R
Immunity. 2024; 57(8):1864-1877.e9.
PMID: 39111315
PMC: 11324406.
DOI: 10.1016/j.immuni.2024.07.003.
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.
Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C
Exp Hematol Oncol. 2024; 13(1):80.
PMID: 39107856
PMC: 11301948.
DOI: 10.1186/s40164-024-00543-1.
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.
Cai S, Yang G, Hu M, Li C, Yang L, Zhang W
Cancer Immunol Immunother. 2024; 73(10):189.
PMID: 39093404
PMC: 11297009.
DOI: 10.1007/s00262-024-03762-x.
Immunological profiling for short-term predictive analysis in PD-1/PD-L1 therapy for lung cancer.
Wang Y, Chen R, Guo Z, Wei W, Wang T, Ouyang R
BMC Cancer. 2024; 24(1):851.
PMID: 39026211
PMC: 11256628.
DOI: 10.1186/s12885-024-12628-5.
Regulation of the PD-1/PD-L1 Axis and NK Cell Dysfunction by Exosomal miR-552-5p in Gastric Cancer.
Tang C, Yang J, Qin J, Wu H, Cui H, Ge L
Dig Dis Sci. 2024; 69(9):3276-3289.
PMID: 39020183
PMC: 11415408.
DOI: 10.1007/s10620-024-08536-0.
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.
Yao Y, Zhang Q, Wei S, Li H, Zhou T, Zhang Q
Transl Cancer Res. 2024; 13(6):2913-2937.
PMID: 38988945
PMC: 11231768.
DOI: 10.21037/tcr-23-2243.
Spatial distribution pattern of immune cells is associated with patient prognosis in colorectal cancer.
Shen R, Huang Y, Kong D, Ma W, Liu J, Zhang H
J Transl Med. 2024; 22(1):606.
PMID: 38951801
PMC: 11218284.
DOI: 10.1186/s12967-024-05418-x.
The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).
Luan J, Liu Y, Cao M, Guo X, Guo N
Oncol Rep. 2024; 52(1).
PMID: 38904200
PMC: 11200153.
DOI: 10.3892/or.2024.8757.
Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence.
Derbal Y
Cancer Control. 2024; 31:10732748241264704.
PMID: 38897721
PMC: 11189021.
DOI: 10.1177/10732748241264704.